MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-04-09 (investing.com)
Masimo at Needham Conference: Strategic Growth and Divestiture Plans By Investing.com
Masimo at Needham Conference: Strategic Growth and Divestiture Plans
Read more
2025-03-05 (pharmiweb.com)
Intracranial Stents Market to Reach USD 3.4 Billion by 2031, Powered by Rising Neurological Challenges and Technological Evolution | TMR -
The intracranial stents market is experiencing rapid growth, fueled by the rising incidence of strokes, aneurysms, and intracranial stenosis. With the increasing demand for minimally invasive procedures and cutting-edge neurovascular treatments, the market is expected to reach USD 3.4 billion by 2031, growing at a C...
Read more
2025-02-28 (openpr.com)
Future Business Opportunities in Medical Marketing Services Outsourcing Market 2025-2032: Forecast with Growth Analysis By Key Players |WebMD, MedPage Today, Outcome Health, Medtronic
Press release - WMR - Future Business Opportunities in Medical Marketing Services Outsourcing Market 2025-2032: Forecast with Growth Analysis By Key Players |WebMD, MedPage Today, Outcome Health, Medtronic - published on openPR.com
Read more
2025-02-27 (vator.tv)
Brainomix partners with Medtronic to expand its AI-powered stroke solution - VatorNews
In the United States alone, more than 795,000 people experience a stroke each year, which is about one in every 40 seconds, causing 1 in 6 deaths from cardiovascular disease. Globally, stroke is a leading cause of disability and death: in 2021, there were 11.9 million new strokes and 93.8 million people living with stroke.
Read more
2025-02-25 (drugdeliverybusiness.com)
FDA clears Tandem Diabetes Care's next-gen automated insulin delivery algorithm for type 2 diabetes
Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type 2 diabetes.
Read more
2025-02-20 (openpr.com)
Wireless Communication Technologies in Healthcare Market to Witness Stunning Growth with Medtronic,Ekahau,Ascom
Press release - HTF Market Intelligence Consulting Private Limited - Wireless Communication Technologies in Healthcare Market to Witness Stunning Growth with Medtronic,Ekahau,Ascom - published on openPR.com
Read more
2025-02-18 (drugdeliverybusiness.com)
Medtronic seeks to expand MiniMed 780G label to type 2 diabetes, submits new CGM to FDA
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin delivery platform.
Read more
2025-02-07 (market.us)
Radiofrequency Ablation Devices Market Set for Growth, Projected to Hit USD 12.5 Billion by 2032
Global Radiofrequency Ablation Devices Market size is expected to be worth around USD 12.5 Billion by 2032 from USD 4.8 Billion in 2023
Read more
2025-01-21 (24x7mag.com)
Medtronic Enhances AiBLE Ecosystem for Spinal Procedures
Medtronic launched new software, hardware, and imaging innovations for its AiBLE ecosystem, aimed at improving spine and cranial surgeries.
Read more
2025-01-15 (24x7mag.com)
Medtronic Enters Deal for U.S. Distribution of Contego Products
Medtronic and Contego Medical have formed an exclusive U.S. distribution agreement, expanding Medtronic’s investment in the company.
Read more
2025-01-15 (medtechdive.com)
CEO Geoff Martha tells JPM crowd Medtronic is ‘stacking growth drivers’ |
New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, Martha said Monday at the J.P. Morgan Healthcare Conference.
Read more
2025-01-08 (aktiencheck.de)
Medtronic shares: new impulses () | .de
Medtronic, the world's leading medical technology group, is recording significant business development at the start of 2025. The company has entered into an exclusive distribution agreement with the Swiss biopharmaceutical company Kuros, which strategically expands the group's product portfolio. On the stock market, Medtronic shares reacted with slight movements and are currently trading at USD 79.88, which corresponds to a minimal increase of 0.04 percent.
Read more